GENE ONLINE|News &
Flu Vaccine Uptake in England Rises by 28 Percent Following Transition to Trivalent Formulation
Flu vaccine uptake in England has risen by 28% during the 2025/26 flu season, according to recent data. This increase coincides with pharmaceutical companies transitioning to trivalent vaccines, following recommendations from the World Health Organization (WHO). The updated vaccine formulation targets three strains of influenza, aiming to enhance protection against the virus.
The shift to trivalent vaccines marks a significant change in flu prevention strategies and reflects efforts to align with global health guidelines. The WHO’s recommendations are based on surveillance data that identifies the most prevalent and potentially harmful flu strains for each season. This adjustment appears to have contributed to higher vaccination rates across England, as public health campaigns emphasized the importance of immunization amid evolving viral threats.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: October 10, 2025
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Zai Lab Presents Preclinical Data on ZL-1503 Targeting IL-13 and IL-31Rα for Itch Relief and Inflammation Reduction in Atopic Diseases
2026-04-18
Study Reveals Temporal Changes in Human Milk Oligosaccharide Profiles and Their Impact on Infant Health
2026-04-18
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
